DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HL): PRELIMINARY RESULTS OF A PHASE II, PROSPECTIVE, ONGOING MULTI square CENTER STUDY BY FONDAZIONE ITALIANA LIN

HAEMATOLOGICA(2014)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要